Celanese Corporation Reports Full Year 2016 and Fourth Quarter Earnings; Maintains Growth Outlook for
2017
Celanese Corporation (NYSE: CE), a global technology and specialty materials company, today reported 2016 GAAP diluted earnings
per share of $6.19 and adjusted earnings per share of $6.61. The company also reported fourth quarter 2016 GAAP diluted earnings
per share of $1.12 and adjusted earnings per share of $1.52. Robust operating models in both Materials Solutions and the Acetyl
Chain contributed to superior performance this year. Advanced Engineered Materials delivered strong results by expanding the
opportunity pipeline which combines one of the broadest polymer portfolios with exceptional application expertise to develop
customer specific solutions. Earlier today, Celanese announced an agreement to acquire Nilit Plastics' nylon compounding division,
which will further enhance both the polymer portfolio and ability to service customers more comprehensively. The Acetyl Chain
delivered differentiated results by leveraging its technology advantage, integrated network and global presence to sustain
profitability in a slow growth environment.
Fourth Quarter and Full Year 2016 Highlights:
|
|
|
Three Months Ended
December 31, |
|
|
|
Year Ended
December 31, |
|
|
|
2016 |
|
|
2015 |
|
|
|
2016 |
|
|
2015 |
|
|
|
(unaudited) |
|
|
|
(In $ millions, except per share data) |
Operating Profit (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Advanced Engineered Materials |
|
|
|
87 |
|
|
|
|
51 |
|
|
|
|
|
350 |
|
|
|
|
235 |
|
Consumer Specialties |
|
|
|
76 |
|
|
|
|
46 |
|
|
|
|
|
302 |
|
|
|
|
262 |
|
Total Materials Solutions |
|
|
|
163 |
|
|
|
|
97 |
|
|
|
|
|
652 |
|
|
|
|
497 |
|
Industrial Specialties |
|
|
|
20 |
|
|
|
|
(4 |
) |
|
|
|
|
105 |
|
|
|
|
72 |
|
Acetyl Intermediates |
|
|
|
66 |
|
|
|
|
(242 |
) |
|
|
|
|
340 |
|
|
|
|
(3 |
) |
Eliminations |
|
|
|
— |
|
|
|
|
— |
|
|
|
|
|
1 |
|
|
|
|
— |
|
Total Acetyl Chain |
|
|
|
86 |
|
|
|
|
(246 |
) |
|
|
|
|
446 |
|
|
|
|
69 |
|
Other Activities |
|
|
|
(132 |
) |
|
|
|
(156 |
) |
|
|
|
|
(205
|
)
|
|
|
|
(240
|
)
|
Total |
|
|
|
117 |
|
|
|
|
(305 |
) |
|
|
|
|
893 |
|
|
|
|
326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
December 31, |
|
|
|
Year Ended
December 31, |
|
|
|
2016 |
|
|
2015 |
|
|
|
2016 |
|
|
2015 |
|
|
|
(unaudited) |
|
|
|
(In $ millions, except per share data) |
Net earnings (loss) |
|
|
|
161 |
|
|
|
|
(301 |
) |
|
|
|
|
906 |
|
|
|
|
285 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBIT(1)(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Advanced Engineered Materials |
|
|
|
121 |
|
|
|
|
85 |
|
|
|
|
|
479 |
|
|
|
|
397 |
|
Consumer Specialties |
|
|
|
106 |
|
|
|
|
109 |
|
|
|
|
|
418 |
|
|
|
|
411 |
|
Total Materials Solutions |
|
|
|
227 |
|
|
|
|
194 |
|
|
|
|
|
897 |
|
|
|
|
808 |
|
Industrial Specialties |
|
|
|
18 |
|
|
|
|
22 |
|
|
|
|
|
106 |
|
|
|
|
110 |
|
Acetyl Intermediates |
|
|
|
68 |
|
|
|
|
60 |
|
|
|
|
|
347 |
|
|
|
|
388 |
|
Eliminations |
|
|
|
— |
|
|
|
|
— |
|
|
|
|
|
1 |
|
|
|
|
— |
|
Total Acetyl Chain |
|
|
|
86 |
|
|
|
|
82 |
|
|
|
|
|
454 |
|
|
|
|
498 |
|
Other Activities |
|
|
|
(24 |
) |
|
|
|
(20 |
) |
|
|
|
|
(73 |
) |
|
|
|
(70 |
) |
Total |
|
|
|
289 |
|
|
|
|
256 |
|
|
|
|
|
1,278 |
|
|
|
|
1,236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Earnings, Cost-Dividend Income, Other Income (Expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Advanced Engineered Materials |
|
|
|
31 |
|
|
|
|
33 |
|
|
|
|
|
122 |
|
|
|
|
151 |
|
Consumer Specialties |
|
|
|
27 |
|
|
|
|
27 |
|
|
|
|
|
110 |
|
|
|
|
108 |
|
Total Materials Solutions |
|
|
|
58 |
|
|
|
|
60 |
|
|
|
|
|
232 |
|
|
|
|
259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating EBITDA(1) |
|
|
|
360 |
|
|
|
|
332 |
|
|
|
|
|
1,566 |
|
|
|
|
1,515 |
|
Diluted EPS - continuing operations |
|
|
$ |
1.12 |
|
|
|
$ |
(2.03 |
) |
|
|
|
$ |
6.19 |
|
|
|
$ |
2.01 |
|
Diluted EPS - total |
|
|
$ |
1.12 |
|
|
|
$ |
(2.03 |
) |
|
|
|
$ |
6.18 |
|
|
|
$ |
2.00 |
|
Adjusted EPS(1) |
|
|
$ |
1.52 |
|
|
|
$ |
1.25 |
|
|
|
|
$ |
6.61 |
|
|
|
$ |
6.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
|
(247 |
) |
|
|
|
(97 |
) |
|
|
|
|
(439 |
) |
|
|
|
(558 |
) |
Net cash provided by (used in) financing activities |
|
|
|
(292 |
) |
|
|
|
(2 |
) |
|
|
|
|
(759 |
) |
|
|
|
(66 |
) |
Net cash provided by (used in) operating activities |
|
|
|
(47 |
) |
|
|
|
136 |
|
|
|
|
|
893 |
|
|
|
|
862 |
|
Free cash flow(1) |
|
|
|
(116 |
) |
|
|
|
74 |
|
|
|
|
|
623 |
|
|
|
|
556 |
|
______________________________ |
(1) |
|
See "Non-US GAAP Financial Measures" below. |
(2) |
|
The company's discussion of adjusted earnings includes use of terms such as "segment
income" and "core income". Those non-GAAP terms are defined below and reconciled in our Non-US GAAP Financial Measures and
Supplemental Information document below. |
|
|
|
"I am pleased to report second highest GAAP earnings per share and highest ever adjusted earnings per share for the year. We had
tremendous success in offsetting typical fourth quarter seasonality and muted demand growth to deliver outstanding results," said
Mark Rohr, chairman and chief executive officer. "Our Materials Solutions core contributed significantly to growth by leveraging
our broad and differentiated polymer portfolio and commercializing unique solutions for customers across applications. To further
advance the momentum in engineered materials (Advanced Engineered Materials excluding affiliates), we announced an agreement to
acquire Nilit Plastics' nylon compounding division which has a comprehensive product portfolio and state-of-the-art production
facilities. The Acetyl Chain continued to press through low global utilization rates and a weak demand landscape by leaning on the
integrated global footprint and expanded commercial flexibility. Strong business performance resulted in another quarter of robust
cash generation that supported $200 million of share buy backs in the quarter for a total of $500 million for the year. In 2016, we
increased dividends per share by 20 percent year over year and returned $201 million in dividends for the year. The success of our
business models in both cores combined with the rigor of our productivity programs has enabled us to continue delivering strong and
sustainable cash flow," said Rohr.
Full Year Business Segment Overview
Materials Solutions
Materials Solutions delivered its second highest GAAP operating profit of $652 million and highest-ever adjusted EBIT of
$897 million for the year. The core demonstrated strong growth over the prior year as volume growth and productivity
initiatives more than offset the decline in tow pricing and lower contributions from affiliates. Advanced Engineered Materials had
its strongest year ever driven primarily by the success of our opportunity pipeline which supported strong volume growth year over
year. In 2016, the number of projects launched exceeded targets, commercializing about 1,385 value-enhancing projects. These
projects spanned across industries and product lines and were supported by deep understanding of customer needs. Recent
acquisitions provide further opportunity to translate and extend the success of this model. Volume in Advanced Engineered Materials
increased year-over-year, led by growth in Asia, but spread across the product portfolio.
Equity earnings from Advanced Engineered Materials affiliates declined $28 million year over year primarily driven by lower
MTBE pricing in Ibn Sina partially offset by growth in earnings from Korea Engineering Plastics and Polyplastics.
Tow pricing was 8 percent lower in 2016 versus the prior year primarily due to a lower industry utilization rate outside of
China but was more than offset by higher volumes and productivity gains. Volume increased compared to last year as the tow industry
recovered from destocking in 2015.
Acetyl Chain
The Acetyl Chain leveraged its position as a global leader across the value chain and its commercial agility to persevere in a
low utilization and deflationary raw materials environment. Pricing for acetyl products was lower in 2016 versus the prior year
primarily due to lower methanol pricing for most of the year which offset productivity improvements. The core grew margin despite
pricing pressure and softer demand by effectively leveraging low-cost facilities in the U.S. Gulf Coast and Singapore. In 2016, the
newest vinyl acetate ethylene (VAE) production unit on Jurong Island, Singapore, came on-line to support growing demand for
ecologically friendly materials in Southeast Asia.
Recent Highlights
- Signed a definitive agreement to acquire the nylon compounding division from Nilit Group, a major
independent producer of high performance nylon resins, fibers and compounds. Celanese will acquire Nilit Plastics’ nylon
compounding product portfolio, customer agreements and manufacturing, technology and commercial facilities.
- On December 1, 2016, completed the transaction to acquire the Forli, Italy based SO.F.TER. Group, one
of the world’s largest independent thermoplastic compounders. SO.F.TER. Group’s sophisticated and modern manufacturing facilities
and product portfolio provide a vehicle for additional growth, investment and synergies.
- Accelerated the launch of 389 projects in the fourth quarter, an all-time record, for a total of
1,385 new project commercializations in 2016 in Advanced Engineered Materials. The growing success of the opportunity pipeline
demonstrates the efficiency and rigor of managing unique customer needs.
- Earned top plastic and automotive industry recognition at the Society of Plastics Engineers' 46th
Annual Automotive Division Innovation Awards Gala in Detroit, Michigan. Celanese won in two categories, Safety and Body Exterior,
as the materials supplier for award-winning components of the all-new 2017 Ford Super Duty pickup.
Fourth Quarter Business Segment Overview
Materials Solutions
Materials Solutions delivered strong growth over last year primarily due to volume growth, lower raw material costs and
productivity initiatives which more than offset lower pricing. Advanced Engineered Materials recorded its second highest fourth
quarter GAAP operating profit of $87 million and record fourth quarter adjusted EBIT of $121 million. Profits grew
significantly over the fourth quarter of 2015, overcoming normal seasonality. The opportunity pipeline drove broad-based growth by
solving unmet customer needs and commercializing projects independent of seasonal trends. A record 389 projects were launched in
the fourth quarter, successfully commercializing products across multiple industries and applications. Productivity combined with
lower raw material costs more than offset mix-driven pricing decline in Advanced Engineered Materials. Volume grew versus the
fourth quarter in 2015, primarily driven by growth in Asia.
Consumer Specialties maintained profitability year over year as productivity initiatives and lower raw material costs offset a
10 percent decline in tow pricing.
Acetyl Chain
The Acetyl Chain demonstrated the strength of its flexible commercial model by improving margins and growing profitability year
over year despite muted demand and a sluggish raw material environment. Productivity gains and a reduction in raw material costs
more than offset pricing pressure and volume decline. Increased optionality from a global asset base enabled reduction in costs
throughout the chain as raw material dynamics evolved. VAM pricing in Asia was lower versus the same quarter last year due to low
industry utilization, while global pricing in emulsion polymers was weaker primarily due to lower raw material costs, mainly VAM.
Volume was lower in VAM in Europe and due to weak demand for EVA polymers in Asia.
Cash Flow
Operating cash flow was $893 million for the year. Free cash flow was $923 million before including $300 million
of voluntary pension deleveraging in the US pension plan. Capex for the year was $246 million and $60 million for the
quarter.
$701 million of cash was returned to shareholders, repurchasing 7.0 million shares for $500 million and distributing
$201 million in dividends for the year. As of December 31, 2016, $531 million remains under the current share
repurchase authorization.
Outlook
"In 2016, we successfully executed on our plans to deliver yet another year of strong growth despite several headwinds. We saw
great success from our opportunity pipeline in Materials Solutions and managed with strength through a difficult operating
environment in the Acetyl Chain. In 2017, we are starting to see early signs of recovery in the Chinese economy while Europe and
the Americas remain stable. Advanced Engineered Materials should continue to unlock value by commercializing new projects and
extending the pipeline model through our recent acquisitions. The prevailing uplift in the raw materials complex is encouraging and
allows us to flex the acetyl value chain to expand margins globally. We believe that the agility of our business models in both the
cores and our commitment to productivity will enable us to grow over the headwinds in tow and currency. At this time, we see a path
to increasing adjusted earnings per share in the range of 8-11% in 2017, with a back-half loaded earnings profile due to major
planned turnarounds in the first half," said Rohr.
Regarding a forward view on a US GAAP basis, we are unable to reconcile forecasted adjusted earnings per share growth to US GAAP
diluted earnings per share without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension
gains/losses, is not practical. The Company's earnings presentation and prepared remarks related to the fourth quarter and full
year results will be posted on its website at www.celanese.com under Investor Relations/Events and Presentations prior to market open on February 1,
2017. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document
posted on our website and available at the link below. See "Non-GAAP Financial Measures" below.
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty
materials used in most major industries and consumer applications. Our two complementary business cores, Acetyl Chain and Materials
Solutions, use the full breadth of Celanese's global chemistry, technology and business expertise to create value for our customers
and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive
impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,300
employees worldwide and had 2016 net sales of $5.4 billion. For more information about Celanese Corporation and its product
offerings, visit www.celanese.com or our blog at www.celaneseblog.com.
Forward-Looking Statements
This release may contain "forward-looking statements," which include information concerning the company's plans, objectives,
goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not
historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions
including the announced stock purchase transaction. There can be no assurance that the company will realize these expectations or
that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to
differ materially from the results expressed or implied in the forward-looking statements contained in this release, including with
respect to the acquisition. These risks and uncertainties include, among other things: changes in general economic, business,
political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry
business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; changes in the
price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene,
methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass
increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain
plant utilization rates and to implement planned capacity additions and expansions; the ability to reduce or maintain their current
levels of production costs and to improve productivity by implementing technological improvements to existing plants; increased
price competition and the introduction of competing products by other companies; market acceptance of our technology; the
ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the company; changes in
the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such
intellectual property; compliance and other costs and potential disruption or interruption of production or operations due to
accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest or other unforeseen
events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of
acts of war or terrorist incidents or as a result of weather or natural disasters; potential liability for remedial actions and
increased costs under existing or future environmental regulations, including those relating to climate change; potential liability
resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other
governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of
indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to
changes in the economy or the chemicals industry; and various other factors discussed from time to time in the company's filings
with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the
company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on
which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.
Non-GAAP Financial Measures
Presentation
This document presents the Company's business segments in two subtotals, reflecting our two cores, the Acetyl Chain and
Materials Solutions, based on similarities among customers, business models and technical processes. As described in the
Company's annual report on Form 10-K and quarterly reports on Form 10-Q, the Acetyl Chain includes the Company's Acetyl
Intermediates segment and the Industrial Specialties segment. Materials Solutions includes the Company's Advanced Engineered
Materials segment and the Consumer Specialties segment.
Use of Non-US GAAP Financial Information
This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, adjusted
earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an
alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance
with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to
Celanese Corporation; for adjusted EBIT margin is operating margin; for adjusted earnings per share is earnings (loss) from
continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by
(used in) operations.
Definitions of Non-US GAAP Financial Measures
- Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net
earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income,
plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US
GAAP Financial Measures and Supplemental Information document). We may provide guidance on adjusted EBIT but are unable to
reconcile forecasted adjusted EBIT to a US GAAP financial measure without unreasonable efforts because a forecast of Certain
Items, such as mark-to-market pension gains and losses, which may be significant, is not practical. Adjusted EBIT margin is
defined by the Company as adjusted EBIT divided by net sales.
- Adjusted EBIT by business segment may also be referred to by management as segment income.
Adjusted EBIT by core (i.e. Acetyl Chain and/or Materials Solutions) may also be referred to by management as core income.
Adjusted EBIT margin by business segment may also be referred to by management as segment income margin. Adjusted EBIT margin by
core may also be referred to by management as core income margin.
- Operating EBITDA is a performance measure used by the Company and is defined by the Company as net
earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income,
plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items,
which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus
depreciation and amortization.
- Adjusted earnings per share is a performance measure used by the Company and is defined by the
Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision)
benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive
restricted stock units and stock options calculated using the treasury method. We may provide guidance on adjusted earnings per
share but are unable to reconcile forecasted adjusted earnings per share to a US GAAP financial measure without unreasonable
efforts because a forecast of Certain Items, such as mark-to-market pension gains and losses, which may be significant, is not
practical.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in
the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense
(benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates
for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where
applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly
basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes, and changes in
management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per
share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events
impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material
change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used
for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP
reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document
summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes
discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will
update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
- Free cash flow is a liquidity measure used by the Company and is defined by the Company as cash
flow from operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or
distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC
("Fairway").
Reconciliation of Non-US GAAP Financial Measures
Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure,
together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial
Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about
February 1, 2017 and also available on our website at www.celanese.com under Financial Information, Non-GAAP Financial Measures, or at this link: http://investors.celanese.com/interactive/lookandfeel/4103411/Non-GAAP.PDF.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been
audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of
the results of operations to be reported for any subsequent period or for the full fiscal year.
Supplemental Information
Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US
GAAP Financial Measures and Supplemental Information document.
|
|
|
|
|
|
|
|
Consolidated Statements of Operations - Unaudited
|
|
|
|
|
|
|
|
Three Months Ended
December 31, |
|
|
|
2016 |
|
|
2015 |
|
|
|
(In $ millions, except share and per share data) |
Net sales |
|
|
1,311 |
|
|
|
1,334 |
|
Cost of sales |
|
|
(989 |
) |
|
|
(1,075 |
) |
Gross profit |
|
|
322 |
|
|
|
259 |
|
Selling, general and administrative expenses |
|
|
(184 |
) |
|
|
(209 |
) |
Amortization of intangible assets |
|
|
(2 |
) |
|
|
(2 |
) |
Research and development expenses |
|
|
(20 |
) |
|
|
(21 |
) |
Other (charges) gains, net |
|
|
1 |
|
|
|
(332 |
) |
Foreign exchange gain (loss), net |
|
|
(2 |
) |
|
|
1 |
|
Gain (loss) on disposition of businesses and asset, net |
|
|
2 |
|
|
|
(1 |
) |
Operating profit (loss) |
|
|
117 |
|
|
|
(305 |
) |
Equity in net earnings (loss) of affiliates |
|
|
41 |
|
|
|
43 |
|
Interest expense |
|
|
(29 |
) |
|
|
(33 |
) |
Refinancing expense |
|
|
— |
|
|
|
— |
|
Interest income |
|
|
1 |
|
|
|
— |
|
Dividend income - cost investments |
|
|
26 |
|
|
|
27 |
|
Other income (expense), net |
|
|
— |
|
|
|
(2 |
) |
Earnings (loss) from continuing operations before tax |
|
|
156 |
|
|
|
(270 |
) |
Income tax (provision) benefit |
|
|
5 |
|
|
|
(31 |
) |
Earnings (loss) from continuing operations |
|
|
161 |
|
|
|
(301 |
) |
Earnings (loss) from operation of discontinued operations |
|
|
— |
|
|
|
— |
|
Gain (loss) on disposition of discontinued operations |
|
|
— |
|
|
|
— |
|
Income tax (provision) benefit from discontinued operations |
|
|
— |
|
|
|
— |
|
Earnings (loss) from discontinued operations |
|
|
— |
|
|
|
— |
|
Net earnings (loss) |
|
|
161 |
|
|
|
(301 |
) |
Net (earnings) loss attributable to noncontrolling interests |
|
|
(1 |
) |
|
|
3 |
|
Net earnings (loss) attributable to Celanese Corporation |
|
|
160 |
|
|
|
(298 |
) |
Amounts attributable to Celanese Corporation |
|
|
|
|
|
|
Earnings (loss) from continuing operations |
|
|
160 |
|
|
|
(298 |
) |
Earnings (loss) from discontinued operations |
|
|
— |
|
|
|
— |
|
Net earnings (loss) |
|
|
160 |
|
|
|
(298 |
) |
Earnings (loss) per common share - basic |
|
|
|
|
|
|
Continuing operations |
|
|
1.13 |
|
|
|
(2.03 |
) |
Discontinued operations |
|
|
— |
|
|
|
— |
|
Net earnings (loss) - basic |
|
|
1.13 |
|
|
|
(2.03 |
) |
Earnings (loss) per common share - diluted |
|
|
|
|
|
|
Continuing operations |
|
|
1.12 |
|
|
|
(2.03 |
) |
Discontinued operations |
|
|
— |
|
|
|
— |
|
Net earnings (loss) - diluted |
|
|
1.12 |
|
|
|
(2.03 |
) |
Weighted average shares (in millions) |
|
|
|
|
|
|
Basic |
|
|
141.9 |
|
|
|
146.9 |
|
Diluted |
|
|
142.6 |
|
|
|
146.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Operations - Unaudited
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2016 |
|
|
2015 |
|
|
|
(In $ millions, except share and per share data) |
Net sales |
|
|
5,389 |
|
|
|
5,674 |
|
Cost of sales |
|
|
(3,984 |
) |
|
|
(4,356 |
) |
Gross profit |
|
|
1,405 |
|
|
|
1,318 |
|
Selling, general and administrative expenses |
|
|
(416 |
) |
|
|
(506 |
) |
Amortization of intangible assets |
|
|
(9 |
) |
|
|
(11 |
) |
Research and development expenses |
|
|
(78 |
) |
|
|
(119 |
) |
Other (charges) gains, net |
|
|
(11 |
) |
|
|
(351 |
) |
Foreign exchange gain (loss), net |
|
|
(1 |
) |
|
|
4 |
|
Gain (loss) on disposition of businesses and asset, net |
|
|
3 |
|
|
|
(9 |
) |
Operating profit (loss) |
|
|
893 |
|
|
|
326 |
|
Equity in net earnings (loss) of affiliates |
|
|
155 |
|
|
|
181 |
|
Interest expense |
|
|
(120 |
) |
|
|
(119 |
) |
Refinancing expense |
|
|
(6 |
) |
|
|
— |
|
Interest income |
|
|
2 |
|
|
|
1 |
|
Dividend income - cost investments |
|
|
108 |
|
|
|
107 |
|
Other income (expense), net |
|
|
(2 |
) |
|
|
(8 |
) |
Earnings (loss) from continuing operations before tax |
|
|
1,030 |
|
|
|
488 |
|
Income tax (provision) benefit |
|
|
(122 |
) |
|
|
(201 |
) |
Earnings (loss) from continuing operations |
|
|
908 |
|
|
|
287 |
|
Earnings (loss) from operation of discontinued operations |
|
|
(3 |
) |
|
|
(3 |
) |
Gain (loss) on disposition of discontinued operations |
|
|
— |
|
|
|
— |
|
Income tax (provision) benefit from discontinued operations |
|
|
1 |
|
|
|
1 |
|
Earnings (loss) from discontinued operations |
|
|
(2 |
) |
|
|
(2 |
) |
Net earnings (loss) |
|
|
906 |
|
|
|
285 |
|
Net (earnings) loss attributable to noncontrolling interests |
|
|
(6 |
) |
|
|
19 |
|
Net earnings (loss) attributable to Celanese Corporation |
|
|
900 |
|
|
|
304 |
|
Amounts attributable to Celanese Corporation |
|
|
|
|
|
|
Earnings (loss) from continuing operations |
|
|
902 |
|
|
|
306 |
|
Earnings (loss) from discontinued operations |
|
|
(2 |
) |
|
|
(2 |
) |
Net earnings (loss) |
|
|
900 |
|
|
|
304 |
|
Earnings (loss) per common share - basic |
|
|
|
|
|
|
Continuing operations |
|
|
6.22 |
|
|
|
2.03 |
|
Discontinued operations |
|
|
(0.01 |
) |
|
|
(0.01 |
) |
Net earnings (loss) - basic |
|
|
6.21 |
|
|
|
2.02 |
|
Earnings (loss) per common share - diluted |
|
|
|
|
|
|
Continuing operations |
|
|
6.19 |
|
|
|
2.01 |
|
Discontinued operations |
|
|
(0.01 |
) |
|
|
(0.01 |
) |
Net earnings (loss) - diluted |
|
|
6.18 |
|
|
|
2.00 |
|
Weighted average shares (in millions) |
|
|
|
|
|
|
Basic |
|
|
144.9 |
|
|
|
150.8 |
|
Diluted |
|
|
145.7 |
|
|
|
152.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Balance Sheets - Unaudited
|
|
|
|
|
|
|
|
|
|
|
As of
December 31,
2016
|
|
|
As of
December 31,
2015
|
|
|
|
(In $ millions) |
ASSETS |
|
|
|
|
|
|
Current Assets |
|
|
|
|
|
|
Cash and cash equivalents |
|
|
638 |
|
|
|
967 |
|
Trade receivables - third party and affiliates, net |
|
|
801 |
|
|
|
706 |
|
Non-trade receivables, net |
|
|
223 |
|
|
|
285 |
|
Inventories |
|
|
720 |
|
|
|
682 |
|
Deferred income taxes |
|
|
— |
|
|
|
68 |
|
Marketable securities, at fair value |
|
|
30 |
|
|
|
30 |
|
Other assets |
|
|
60 |
|
|
|
49 |
|
Total current assets |
|
|
2,472 |
|
|
|
2,787 |
|
Investments in affiliates |
|
|
852 |
|
|
|
838 |
|
Property, plant and equipment, net |
|
|
3,577 |
|
|
|
3,609 |
|
Deferred income taxes |
|
|
159 |
|
|
|
222 |
|
Other assets |
|
|
307 |
|
|
|
300 |
|
Goodwill |
|
|
796 |
|
|
|
705 |
|
Intangible assets, net |
|
|
194 |
|
|
|
125 |
|
Total assets |
|
|
8,357 |
|
|
|
8,586 |
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
Short-term borrowings and current installments of long-term debt - third party and
affiliates |
|
|
118 |
|
|
|
513 |
|
Trade payables - third party and affiliates |
|
|
625 |
|
|
|
587 |
|
Other liabilities |
|
|
322 |
|
|
|
330 |
|
Deferred income taxes |
|
|
— |
|
|
|
30 |
|
Income taxes payable |
|
|
12 |
|
|
|
90 |
|
Total current liabilities |
|
|
1,077 |
|
|
|
1,550 |
|
Long-term debt |
|
|
2,890 |
|
|
|
2,468 |
|
Deferred income taxes |
|
|
130 |
|
|
|
136 |
|
Uncertain tax positions |
|
|
131 |
|
|
|
167 |
|
Benefit obligations |
|
|
893 |
|
|
|
1,189 |
|
Other liabilities |
|
|
215 |
|
|
|
247 |
|
Commitments and Contingencies |
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
Preferred stock |
|
|
— |
|
|
|
— |
|
Common stock |
|
|
— |
|
|
|
— |
|
Treasury stock, at cost |
|
|
(1,531 |
) |
|
|
(1,031 |
) |
Additional paid-in capital |
|
|
157 |
|
|
|
136 |
|
Retained earnings |
|
|
4,320 |
|
|
|
3,621 |
|
Accumulated other comprehensive income (loss), net |
|
|
(358 |
) |
|
|
(348 |
) |
Total Celanese Corporation stockholders' equity |
|
|
2,588 |
|
|
|
2,378 |
|
Noncontrolling interests |
|
|
433 |
|
|
|
451 |
|
Total equity |
|
|
3,021 |
|
|
|
2,829 |
|
Total liabilities and equity |
|
|
8,357 |
|
|
|
8,586 |
|
|
|
|
|
|
|
|
|
|
Non-US GAAP Financial Measures and Supplemental Information
February 1, 2017
In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a
consolidated basis.
Purpose
The purpose of this document is to provide information of interest to investors, analysts and other parties including
supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures.
This document is updated quarterly.
Presentation
This document presents the Company's business segments in two subtotals, reflecting our two cores, the Acetyl Chain and
Materials Solutions, based on similarities among customers, business models and technical processes. As described in the
Company's annual report on Form 10-K and quarterly reports on Form 10-Q, the Acetyl Chain includes the Company's Acetyl
Intermediates segment and the Industrial Specialties segment. Materials Solutions includes the Company's Advanced Engineered
Materials segment and the Consumer Specialties segment.
Use of Non-US GAAP Financial Measures
From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our
earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these
purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of
historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments
that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US
GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are
excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to
generally accepted accounting principles in the United States.
Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other
parties because the Company believes them to be important supplemental measures for assessing our financial and operating results
and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be
viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit
(loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities),
earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the
context of our complete audited and unaudited financial results for the given period, which are available on the Investor
Relations/Financial Information/SEC Filings page of our website, www.celanese.com. The definition and method of calculation of the non-GAAP financial measures used herein may
be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other
parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's
non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating
results of the Company nor are they intended to be predictive or projections of future results.
Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in
this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Investor Relations/Financial
Information/Non-GAAP Financial Measures page of our website, www.celanese.com, to the extent practicable, the most directly comparable financial measure calculated and
presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we
reference and such comparable GAAP financial measure.
This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the
Company.
Specific Measures Used
This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating
EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net
debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in
accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss)
attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating
profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss)
from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash
flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss)
attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt
and Celanese Corporation stockholders' equity.
Definitions
- Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net
earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income,
plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe
that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating
and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or
restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations
because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and
evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We may
provide guidance on adjusted EBIT but are unable to reconcile forecasted adjusted EBIT to a US GAAP financial measure without
unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains and losses, which may be
significant, is not practical. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted
EBIT margin has the same uses and limitations as Adjusted EBIT.
- Adjusted EBIT by business segment may also be referred to by management as segment income.
Adjusted EBIT by core (i.e. Acetyl Chain and/or Materials Solutions) may also be referred to by management as core income.
Adjusted EBIT margin by business segment may also be referred to by management as segment income margin. Adjusted EBIT margin by
core may also be referred to by management as core income margin.
- Operating EBITDA is a performance measure used by the Company and is defined by the Company as net
earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income,
plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items,
which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus
depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors,
analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is
defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as
Operating EBITDA.
- Operating profit (loss) attributable to Celanese Corporation is defined by the Company as
operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit
(loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and
other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by
the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable
to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese
Corporation.
- Adjusted earnings per share is a performance measure used by the Company and is defined by the
Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision)
benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive
restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share
provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our
primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and
as a performance metric in the Company's incentive compensation plan. We may provide guidance on adjusted earnings per share but
are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure without unreasonable efforts because a
forecast of Certain Items, such as mark-to-market pension gains and losses, which may be significant, is not practical.
Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in
the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense
(benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates
for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where
applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly
basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's
assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax
rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting
the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the
range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted
earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any
given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate.
The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the
year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual
results.
- Free cash flow is a liquidity measure used by the Company and is defined by the Company as net
cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for capital
contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol
LLC ("Fairway"). We believe that free cash flow provides useful information to management, investors, analysts and other parties
in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash
generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our
business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash
requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and
postretirement funding obligations.
- Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that
net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's
capital structure and credit quality assessment.
- Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected
using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and
Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to
management, investors, analysts and other parties in order to assess our income generation from the point of view of our
stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company
yields competitive returns. In addition, achievement of certain predetermined targets relating to return on invested capital
(adjusted) is one of the factors we consider in determining the amount of performance-based compensation received by our
management.
Supplemental Information
Supplemental Information we believe to be of interest to investors, analysts and other parties includes the
following:
- Net sales for Materials Solutions, the Acetyl Chain and each of our business segments and the
percentage increase or decrease in net sales attributable to price, volume, currency and other factors for Materials Solutions,
the Acetyl Chain and each of our business segments.
- Cash dividends received from our equity and cost investments.
- For those consolidated ventures in which the Company owns or is exposed to less than 100% of the
economics, the outside stockholders' interests are shown as NCI. Beginning in 2014, this includes Fairway for which the Company's
ownership percentage is 50%. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable
NCI.
Results Unaudited
The results in this document, together with the adjustments made to present the results on a comparable basis, have not been
audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of
the results of operations to be reported for any subsequent period or for the full fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 1 |
|
|
|
Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP
Measures - Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Net earnings (loss) attributable to Celanese Corporation |
|
|
900 |
|
|
|
160 |
|
|
|
262 |
|
|
221 |
|
|
257 |
|
|
|
304 |
|
|
|
(298 |
) |
|
|
161 |
|
|
205 |
|
|
|
236 |
(Earnings) loss from discontinued operations |
|
|
2 |
|
|
|
— |
|
|
|
3 |
|
|
— |
|
|
(1 |
) |
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
2 |
|
|
|
— |
Interest income |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
— |
|
|
— |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
— |
|
|
|
— |
|
|
(1 |
) |
|
|
— |
Interest expense |
|
|
120 |
|
|
|
29 |
|
|
|
28 |
|
|
30 |
|
|
33 |
|
|
|
119 |
|
|
|
33 |
|
|
|
29 |
|
|
30 |
|
|
|
27 |
Refinancing expense |
|
|
6 |
|
|
|
— |
|
|
|
4 |
|
|
— |
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
Income tax provision (benefit) |
|
|
122 |
|
|
|
(5 |
) |
|
|
15 |
|
|
52 |
|
|
60 |
|
|
|
201 |
|
|
|
31 |
|
|
|
74 |
|
|
24 |
|
|
|
72 |
Certain Items attributable to Celanese Corporation (Table 8)
|
|
|
130 |
|
|
|
106 |
|
|
|
7 |
|
|
9 |
|
|
8 |
|
|
|
611 |
|
|
|
490 |
|
|
|
41 |
|
|
65 |
|
|
|
15 |
Adjusted EBIT |
|
|
1,278 |
|
|
|
289 |
|
|
|
319 |
|
|
312 |
|
|
358 |
|
|
|
1,236 |
|
|
|
256 |
|
|
|
305 |
|
|
325 |
|
|
|
350 |
Depreciation and amortization expense(1) |
|
|
288 |
|
|
|
71 |
|
|
|
71 |
|
|
73 |
|
|
73 |
|
|
|
279 |
|
|
|
76 |
|
|
|
70 |
|
|
66 |
|
|
|
67 |
Operating EBITDA |
|
|
1,566 |
|
|
|
360 |
|
|
|
390 |
|
|
385 |
|
|
431 |
|
|
|
1,515 |
|
|
|
332 |
|
|
|
375 |
|
|
391 |
|
|
|
417 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Advanced Engineered Materials |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
Consumer Specialties |
|
|
1 |
|
|
|
— |
|
|
|
1 |
|
|
— |
|
|
— |
|
|
|
10 |
|
|
|
10 |
|
|
|
— |
|
|
— |
|
|
|
— |
Industrial Specialties |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
— |
|
|
|
28 |
|
|
|
18 |
|
|
|
10 |
|
|
— |
|
|
|
— |
Acetyl Intermediates |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
— |
|
|
|
40 |
|
|
|
1 |
|
|
|
— |
|
|
39 |
|
|
|
— |
Other Activities(2) |
|
|
1 |
|
|
|
1 |
|
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
Accelerated depreciation and amortization expense |
|
|
2 |
|
|
|
1 |
|
|
|
1 |
|
|
— |
|
|
— |
|
|
|
78 |
|
|
|
29 |
|
|
|
10 |
|
|
39 |
|
|
|
— |
Depreciation and amortization expense(1) |
|
|
288 |
|
|
|
71 |
|
|
|
71 |
|
|
73 |
|
|
73 |
|
|
|
279 |
|
|
|
76 |
|
|
|
70 |
|
|
66 |
|
|
|
67 |
Total depreciation and amortization expense |
|
|
290 |
|
|
|
72 |
|
|
|
72 |
|
|
73 |
|
|
73 |
|
|
|
357 |
|
|
|
105 |
|
|
|
80 |
|
|
105 |
|
|
|
67 |
______________________________ |
(1)
|
|
Excludes accelerated depreciation and amortization expense as detailed in the table
above, which amounts are included in Certain Items above. |
(2)
|
|
Other Activities includes corporate Selling, general and administrative ("SG&A")
expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost,
expected return on plan assets and net actuarial gains and losses). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating
EBITDA - Non-GAAP Measures - Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions, except percentages) |
Operating Profit (Loss) / Operating Margin |
Materials Solutions |
|
|
652 |
|
|
|
27.5 |
% |
|
|
163 |
|
|
|
27.7 |
% |
|
|
161 |
|
|
|
27.3 |
% |
|
|
162 |
|
|
|
27.0 |
% |
|
|
166 |
|
|
|
27.9 |
% |
|
|
497 |
|
|
|
21.7 |
% |
|
|
97 |
|
|
|
17.4 |
% |
|
|
135 |
|
|
|
23.6 |
% |
|
|
144 |
|
|
|
24.2 |
% |
|
|
121 |
|
|
|
21.2 |
% |
Acetyl Chain(1) |
|
|
446 |
|
|
|
14.2 |
% |
|
|
86 |
|
|
|
11.5 |
% |
|
|
108 |
|
|
|
14.2 |
% |
|
|
107 |
|
|
|
13.7 |
% |
|
|
145 |
|
|
|
17.3 |
% |
|
|
69 |
|
|
|
2.0 |
% |
|
|
(246 |
) |
|
|
(30.3 |
)% |
|
|
73 |
|
|
|
8.4 |
% |
|
|
82 |
|
|
|
9.0 |
% |
|
|
160 |
|
|
|
17.6 |
% |
Other Activities(2) |
|
|
(205 |
) |
|
|
|
|
|
(132 |
) |
|
|
|
|
|
(23 |
) |
|
|
|
|
|
(26 |
) |
|
|
|
|
|
(24 |
) |
|
|
|
|
|
(240 |
) |
|
|
|
|
|
(156 |
) |
|
|
|
|
|
(22 |
) |
|
|
|
|
|
(38 |
) |
|
|
|
|
|
(24 |
) |
|
|
|
Total |
|
|
893 |
|
|
|
16.6 |
% |
|
|
117 |
|
|
|
8.9 |
% |
|
|
246 |
|
|
|
18.6 |
% |
|
|
243 |
|
|
|
18.0 |
% |
|
|
287 |
|
|
|
20.4 |
% |
|
|
326 |
|
|
|
5.7 |
% |
|
|
(305 |
) |
|
|
(22.9 |
)% |
|
|
186 |
|
|
|
13.2 |
% |
|
|
188 |
|
|
|
12.7 |
% |
|
|
257 |
|
|
|
17.7 |
% |
Less: Net Earnings (Loss) Attributable to NCI(1) |
|
|
6 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
(19 |
) |
|
|
|
|
|
(3 |
) |
|
|
|
|
|
(10 |
) |
|
|
|
|
|
(4 |
) |
|
|
|
|
|
(2 |
) |
|
|
|
Operating Profit (Loss) Attributable to Celanese Corporation |
|
|
887 |
|
|
|
16.5 |
% |
|
|
116 |
|
|
|
8.8 |
% |
|
|
245 |
|
|
|
18.5 |
% |
|
|
241 |
|
|
|
17.8 |
% |
|
|
285 |
|
|
|
20.3 |
% |
|
|
345 |
|
|
|
6.1 |
% |
|
|
(302 |
) |
|
|
(22.6 |
)% |
|
|
196 |
|
|
|
13.9 |
% |
|
|
192 |
|
|
|
13.0 |
% |
|
|
259 |
|
|
|
17.9 |
% |
Operating Profit (Loss) / Operating Margin Attributable to Celanese
Corporation |
Advanced Engineered Materials |
|
|
350 |
|
|
|
24.2 |
% |
|
|
87 |
|
|
|
23.9 |
% |
|
|
93 |
|
|
|
25.5 |
% |
|
|
82 |
|
|
|
22.5 |
% |
|
|
88 |
|
|
|
25.1 |
% |
|
|
235 |
|
|
|
17.7 |
% |
|
|
51 |
|
|
|
16.4 |
% |
|
|
58 |
|
|
|
17.8 |
% |
|
|
67 |
|
|
|
19.4 |
% |
|
|
59 |
|
|
|
17.2 |
% |
Consumer Specialties |
|
|
302 |
|
|
|
32.5 |
% |
|
|
76 |
|
|
|
33.8 |
% |
|
|
68 |
|
|
|
30.2 |
% |
|
|
80 |
|
|
|
34.0 |
% |
|
|
78 |
|
|
|
32.0 |
% |
|
|
262 |
|
|
|
27.0 |
% |
|
|
46 |
|
|
|
18.7 |
% |
|
|
77 |
|
|
|
31.2 |
% |
|
|
77 |
|
|
|
30.9 |
% |
|
|
62 |
|
|
|
27.3 |
% |
Total Materials Solutions |
|
|
652 |
|
|
|
27.5 |
% |
|
|
163 |
|
|
|
27.7 |
% |
|
|
161 |
|
|
|
27.3 |
% |
|
|
162 |
|
|
|
27.0 |
% |
|
|
166 |
|
|
|
27.9 |
% |
|
|
497 |
|
|
|
21.7 |
% |
|
|
97 |
|
|
|
17.4 |
% |
|
|
135 |
|
|
|
23.6 |
% |
|
|
144 |
|
|
|
24.2 |
% |
|
|
121 |
|
|
|
21.2 |
% |
Industrial Specialties |
|
|
105 |
|
|
|
10.7 |
% |
|
|
20 |
|
|
|
9.1 |
% |
|
|
25 |
|
|
|
10.2 |
% |
|
|
29 |
|
|
|
11.1 |
% |
|
|
31 |
|
|
|
12.3 |
% |
|
|
72 |
|
|
|
6.7 |
% |
|
|
(4 |
) |
|
|
(1.7 |
)% |
|
|
19 |
|
|
|
6.9 |
% |
|
|
28 |
|
|
|
9.8 |
% |
|
|
29 |
|
|
|
10.3 |
% |
Acetyl Intermediates(1) |
|
|
334 |
|
|
|
13.7 |
% |
|
|
65 |
|
|
|
10.9 |
% |
|
|
82 |
|
|
|
13.9 |
% |
|
|
75 |
|
|
|
12.7 |
% |
|
|
112 |
|
|
|
16.9 |
% |
|
|
16 |
|
|
|
0.6 |
% |
|
|
(239 |
) |
|
|
(37.1 |
)% |
|
|
64 |
|
|
|
9.4 |
% |
|
|
58 |
|
|
|
8.2 |
% |
|
|
133 |
|
|
|
18.7 |
% |
Eliminations |
|
|
1 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
Total Acetyl Chain |
|
|
440 |
|
|
|
14.0 |
% |
|
|
85 |
|
|
|
11.3 |
% |
|
|
107 |
|
|
|
14.0 |
% |
|
|
105 |
|
|
|
13.5 |
% |
|
|
143 |
|
|
|
17.0 |
% |
|
|
88 |
|
|
|
2.5 |
% |
|
|
(243 |
) |
|
|
(29.9 |
)% |
|
|
83 |
|
|
|
9.5 |
% |
|
|
86 |
|
|
|
9.4 |
% |
|
|
162 |
|
|
|
17.8 |
% |
Other Activities(2) |
|
|
(205 |
) |
|
|
|
|
|
(132 |
) |
|
|
|
|
|
(23 |
) |
|
|
|
|
|
(26 |
) |
|
|
|
|
|
(24 |
) |
|
|
|
|
|
(240 |
) |
|
|
|
|
|
(156 |
) |
|
|
|
|
|
(22 |
) |
|
|
|
|
|
(38 |
) |
|
|
|
|
|
(24 |
) |
|
|
|
Total |
|
|
887 |
|
|
|
16.5 |
% |
|
|
116 |
|
|
|
8.8 |
% |
|
|
245 |
|
|
|
18.5 |
% |
|
|
241 |
|
|
|
17.8 |
% |
|
|
285 |
|
|
|
20.3 |
% |
|
|
345 |
|
|
|
6.1 |
% |
|
|
(302 |
) |
|
|
(22.6 |
)% |
|
|
196 |
|
|
|
13.9 |
% |
|
|
192 |
|
|
|
13.0 |
% |
|
|
259 |
|
|
|
17.9 |
% |
Equity Earnings, Cost-Dividend Income, Other Income (Expense)
Attributable to Celanese Corporation |
Advanced Engineered Materials |
|
|
122 |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
33 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
151 |
|
|
(3)
|
|
|
33 |
|
|
|
|
|
|
44 |
|
|
|
|
|
31 |
|
|
|
|
|
|
43 |
|
|
|
|
Consumer Specialties |
|
|
110 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
28 |
|
|
|
|
|
|
28 |
|
|
|
|
|
|
108 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
26 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
28 |
|
|
|
|
Total Materials Solutions |
|
|
232 |
|
|
|
|
|
|
58 |
|
|
|
|
|
|
60 |
|
|
|
|
|
|
55 |
|
|
|
|
|
|
59 |
|
|
|
|
|
|
259 |
|
|
|
|
|
|
60 |
|
|
|
|
|
|
70 |
|
|
|
|
|
|
58 |
|
|
|
|
|
|
71 |
|
|
|
|
Industrial Specialties |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
Acetyl Intermediates |
|
|
7 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
1 |
|
|
|
|
Total Acetyl Chain |
|
|
7 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
1 |
|
|
|
|
Other Activities(2) |
|
|
22 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
14 |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
(4 |
) |
|
|
|
|
|
9 |
|
|
|
|
|
|
4 |
|
|
|
|
Total |
|
|
261 |
|
|
|
|
|
|
67 |
|
|
|
|
|
|
67 |
|
|
|
|
|
|
62 |
|
|
|
|
|
|
65 |
|
|
|
|
|
|
280 |
|
|
|
|
|
|
68 |
|
|
|
|
|
|
68 |
|
|
|
|
|
|
68 |
|
|
|
|
|
|
76 |
|
|
|
|
Certain Items Attributable to Celanese Corporation (Table 8)
|
Advanced Engineered Materials |
|
|
7 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
2 |
|
|
|
|
Consumer Specialties |
|
|
6 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
41 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
2 |
|
|
|
|
Total Materials Solutions |
|
|
13 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
52 |
|
|
|
|
|
|
37 |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
4 |
|
|
|
|
Industrial Specialties |
|
|
1 |
|
|
|
|
|
|
(2 |
) |
|
|
|
|
|
— |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
38 |
|
|
|
|
|
|
26 |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
1 |
|
|
|
|
Acetyl Intermediates |
|
|
6 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
365 |
|
|
|
|
|
|
296 |
|
|
|
|
|
|
18 |
|
|
|
|
|
|
48 |
|
|
|
|
|
|
3 |
|
|
|
|
Total Acetyl Chain |
|
|
7 |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
1 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
403 |
|
|
|
|
|
|
322 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
50 |
|
|
|
|
|
|
4 |
|
|
|
|
Other Activities(2) |
|
|
110 |
|
|
|
|
|
|
101 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
156 |
|
|
|
|
|
|
131 |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
7 |
|
|
|
|
Total |
|
|
130 |
|
|
|
|
|
|
106 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
611 |
|
|
|
|
|
|
490 |
|
|
|
|
|
|
41 |
|
|
|
|
|
|
65 |
|
|
|
|
|
|
15 |
|
|
|
|
Adjusted EBIT / Adjusted EBIT Margin |
Advanced Engineered Materials |
|
|
479 |
|
|
|
33.2 |
% |
|
|
121 |
|
|
|
33.2 |
% |
|
|
127 |
|
|
|
34.8 |
% |
|
|
111 |
|
|
|
30.4 |
% |
|
|
120 |
|
|
|
34.3 |
% |
|
|
397 |
|
|
|
29.9 |
% |
|
|
85 |
|
|
|
27.3 |
% |
|
|
106 |
|
|
|
32.5 |
% |
|
|
102 |
|
|
|
29.5 |
% |
|
|
104 |
|
|
|
30.3 |
% |
Consumer Specialties |
|
|
418 |
|
|
|
45.0 |
% |
|
|
106 |
|
|
|
47.1 |
% |
|
|
98 |
|
|
|
43.6 |
% |
|
|
108 |
|
|
|
46.0 |
% |
|
|
106 |
|
|
|
43.4 |
% |
|
|
411 |
|
|
|
42.4 |
% |
|
|
109 |
|
|
|
44.3 |
% |
|
|
105 |
|
|
|
42.5 |
% |
|
|
105 |
|
|
|
42.2 |
% |
|
|
92 |
|
|
|
40.5 |
% |
Total Materials Solutions |
|
|
897 |
|
|
|
37.8 |
% |
|
|
227 |
|
|
|
38.5 |
% |
|
|
225 |
|
|
|
38.1 |
% |
|
|
219 |
|
|
|
36.5 |
% |
|
|
226 |
|
|
|
38.0 |
% |
|
|
808 |
|
|
|
35.2 |
% |
|
|
194 |
|
|
|
34.8 |
% |
|
|
211 |
|
|
|
36.8 |
% |
|
|
207 |
|
|
|
34.8 |
% |
|
|
196 |
|
|
|
34.4 |
% |
Industrial Specialties |
|
|
106 |
|
|
|
10.8 |
% |
|
|
18 |
|
|
|
8.2 |
% |
|
|
25 |
|
|
|
10.2 |
% |
|
|
30 |
|
|
|
11.5 |
% |
|
|
33 |
|
|
|
13.0 |
% |
|
|
110 |
|
|
|
10.2 |
% |
|
|
22 |
|
|
|
9.2 |
% |
|
|
28 |
|
|
|
10.2 |
% |
|
|
30 |
|
|
|
10.5 |
% |
|
|
30 |
|
|
|
10.6 |
% |
Acetyl Intermediates |
|
|
347 |
|
|
|
14.2 |
% |
|
|
68 |
|
|
|
11.4 |
% |
|
|
84 |
|
|
|
14.3 |
% |
|
|
80 |
|
|
|
13.5 |
% |
|
|
115 |
|
|
|
17.3 |
% |
|
|
388 |
|
|
|
14.1 |
% |
|
|
60 |
|
|
|
9.3 |
% |
|
|
84 |
|
|
|
12.4 |
% |
|
|
107 |
|
|
|
15.1 |
% |
|
|
137 |
|
|
|
19.2 |
% |
Eliminations |
|
|
1 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
Total Acetyl Chain |
|
|
454 |
|
|
|
14.5 |
% |
|
|
86 |
|
|
|
11.5 |
% |
|
|
109 |
|
|
|
14.3 |
% |
|
|
111 |
|
|
|
14.2 |
% |
|
|
148 |
|
|
|
17.6 |
% |
|
|
498 |
|
|
|
14.2 |
% |
|
|
82 |
|
|
|
10.1 |
% |
|
|
112 |
|
|
|
12.8 |
% |
|
|
137 |
|
|
|
15.0 |
% |
|
|
167 |
|
|
|
18.4 |
% |
Other Activities(2) |
|
|
(73 |
) |
|
|
|
|
|
(24 |
) |
|
|
|
|
|
(15 |
) |
|
|
|
|
|
(18 |
) |
|
|
|
|
|
(16 |
) |
|
|
|
|
|
(70 |
) |
|
|
|
|
|
(20 |
) |
|
|
|
|
|
(18 |
) |
|
|
|
|
|
(19 |
) |
|
|
|
|
|
(13 |
) |
|
|
|
Total |
|
|
1,278 |
|
|
|
23.7 |
% |
|
|
289 |
|
|
|
22.0 |
% |
|
|
319 |
|
|
|
24.1 |
% |
|
|
312 |
|
|
|
23.1 |
% |
|
|
358 |
|
|
|
25.5 |
% |
|
|
1,236 |
|
|
|
21.8 |
% |
|
|
256 |
|
|
|
19.2 |
% |
|
|
305 |
|
|
|
21.6 |
% |
|
|
325 |
|
|
|
22.0 |
% |
|
|
350 |
|
|
|
24.1 |
% |
___________________________
|
(1)
|
|
Net earnings (loss) attributable to NCI is included within the Acetyl Intermediates
segment. |
(2)
|
|
Other Activities includes corporate SG&A expenses, the results of captive
insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net
actuarial gains and losses). |
(3)
|
|
Includes $150 million of Equity in net earnings (loss) of affiliates and $1 million of Other
income.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating
EBITDA - Non-GAAP Measures - Unaudited (cont.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions, except percentages) |
Depreciation and Amortization Expense(1) |
Advanced Engineered Materials |
|
|
92 |
|
|
|
|
|
|
21 |
|
|
|
|
|
|
22 |
|
|
|
|
|
|
25 |
|
|
|
|
|
|
24 |
|
|
|
|
|
|
99 |
|
|
|
|
|
|
24 |
|
|
|
|
|
|
26 |
|
|
|
|
|
|
24 |
|
|
|
|
|
|
25 |
|
|
|
|
Consumer Specialties |
|
|
44 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
50 |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
15 |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
11 |
|
|
|
|
Total Materials Solutions |
|
|
136 |
|
|
|
|
|
|
32 |
|
|
|
|
|
|
33 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
35 |
|
|
|
|
|
|
149 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
41 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
36 |
|
|
|
|
Industrial Specialties |
|
|
34 |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
8 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
7 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
10 |
|
|
|
|
Acetyl Intermediates |
|
|
107 |
|
|
|
|
|
|
26 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
83 |
|
|
|
|
|
|
29 |
|
|
|
|
|
|
17 |
|
|
|
|
|
|
18 |
|
|
|
|
|
|
19 |
|
|
|
|
Total Acetyl Chain |
|
|
141 |
|
|
|
|
|
|
35 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
35 |
|
|
|
|
|
|
35 |
|
|
|
|
|
|
119 |
|
|
|
|
|
|
36 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
27 |
|
|
|
|
|
|
29 |
|
|
|
|
Other Activities(2) |
|
|
11 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
11 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
2 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
2 |
|
|
|
|
Total |
|
|
288 |
|
|
|
|
|
|
71 |
|
|
|
|
|
|
71 |
|
|
|
|
|
|
73 |
|
|
|
|
|
|
73 |
|
|
|
|
|
|
279 |
|
|
|
|
|
|
76 |
|
|
|
|
|
|
70 |
|
|
|
|
|
|
66 |
|
|
|
|
|
|
67 |
|
|
|
|
Operating EBITDA / Operating EBITDA Margin |
Advanced Engineered Materials |
|
|
571 |
|
|
|
39.5 |
% |
|
|
142 |
|
|
|
39.0 |
% |
|
|
149 |
|
|
|
40.8 |
% |
|
|
136 |
|
|
|
37.3 |
% |
|
|
144 |
|
|
|
41.1 |
% |
|
|
496 |
|
|
|
37.4 |
% |
|
|
109 |
|
|
|
35.0 |
% |
|
|
132 |
|
|
|
40.5 |
% |
|
|
126 |
|
|
|
36.4 |
% |
|
|
129 |
|
|
|
37.6 |
% |
Consumer Specialties |
|
|
462 |
|
|
|
49.7 |
% |
|
|
117 |
|
|
|
52.0 |
% |
|
|
109 |
|
|
|
48.4 |
% |
|
|
119 |
|
|
|
50.6 |
% |
|
|
117 |
|
|
|
48.0 |
% |
|
|
461 |
|
|
|
47.6 |
% |
|
|
121 |
|
|
|
49.2 |
% |
|
|
120 |
|
|
|
48.6 |
% |
|
|
117 |
|
|
|
47.0 |
% |
|
|
103 |
|
|
|
45.4 |
% |
Total Materials Solutions |
|
|
1,033 |
|
|
|
43.5 |
% |
|
|
259 |
|
|
|
44.0 |
% |
|
|
258 |
|
|
|
43.7 |
% |
|
|
255 |
|
|
|
42.5 |
% |
|
|
261 |
|
|
|
43.9 |
% |
|
|
957 |
|
|
|
41.7 |
% |
|
|
230 |
|
|
|
41.3 |
% |
|
|
252 |
|
|
|
44.0 |
% |
|
|
243 |
|
|
|
40.8 |
% |
|
|
232 |
|
|
|
40.7 |
% |
Industrial Specialties |
|
|
140 |
|
|
|
14.3 |
% |
|
|
27 |
|
|
|
12.3 |
% |
|
|
34 |
|
|
|
13.9 |
% |
|
|
38 |
|
|
|
14.5 |
% |
|
|
41 |
|
|
|
16.2 |
% |
|
|
146 |
|
|
|
13.5 |
% |
|
|
29 |
|
|
|
12.1 |
% |
|
|
38 |
|
|
|
13.9 |
% |
|
|
39 |
|
|
|
13.6 |
% |
|
|
40 |
|
|
|
14.2 |
% |
Acetyl Intermediates |
|
|
454 |
|
|
|
18.6 |
% |
|
|
94 |
|
|
|
15.7 |
% |
|
|
111 |
|
|
|
18.8 |
% |
|
|
107 |
|
|
|
18.1 |
% |
|
|
142 |
|
|
|
21.4 |
% |
|
|
471 |
|
|
|
17.2 |
% |
|
|
89 |
|
|
|
13.8 |
% |
|
|
101 |
|
|
|
14.9 |
% |
|
|
125 |
|
|
|
17.7 |
% |
|
|
156 |
|
|
|
21.9 |
% |
Eliminations |
|
|
1 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
1 |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
Total Acetyl Chain |
|
|
595 |
|
|
|
19.0 |
% |
|
|
121 |
|
|
|
16.2 |
% |
|
|
145 |
|
|
|
19.0 |
% |
|
|
146 |
|
|
|
18.7 |
% |
|
|
183 |
|
|
|
21.8 |
% |
|
|
617 |
|
|
|
17.6 |
% |
|
|
118 |
|
|
|
14.5 |
% |
|
|
139 |
|
|
|
15.9 |
% |
|
|
164 |
|
|
|
18.0 |
% |
|
|
196 |
|
|
|
21.6 |
% |
Other Activities(2) |
|
|
(62 |
) |
|
|
|
|
|
(20 |
) |
|
|
|
|
|
(13 |
) |
|
|
|
|
|
(16 |
) |
|
|
|
|
|
(13 |
) |
|
|
|
|
|
(59 |
) |
|
|
|
|
|
(16 |
) |
|
|
|
|
|
(16 |
) |
|
|
|
|
|
(16 |
) |
|
|
|
|
|
(11 |
) |
|
|
|
Total |
|
|
1,566 |
|
|
|
29.1 |
% |
|
|
360 |
|
|
|
27.5 |
% |
|
|
390 |
|
|
|
29.5 |
% |
|
|
385 |
|
|
|
28.5 |
% |
|
|
431 |
|
|
|
30.7 |
% |
|
|
1,515 |
|
|
|
26.7 |
% |
|
|
332 |
|
|
|
24.9 |
% |
|
|
375 |
|
|
|
26.5 |
% |
|
|
391 |
|
|
|
26.5 |
% |
|
|
417 |
|
|
|
28.8 |
% |
___________________________ |
(1)
|
|
Excludes accelerated depreciation and amortization expense, which amounts are
included in Certain Items above. See Table 1 for details. |
(2)
|
|
Other Activities includes corporate SG&A expenses, the results of captive
insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net
actuarial gains and losses). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 3 |
|
|
|
|
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP
Measure - Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
Q4 '16 |
|
Q3 '16 |
|
Q2 '16 |
|
Q1 '16 |
|
2015 |
|
Q4 '15 |
|
Q3 '15 |
|
Q2 '15 |
|
Q1 '15 |
|
|
|
|
|
|
|
|
|
|
|
per share
|
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
per share |
|
|
|
|
|
|
|
|
|
(In $ millions, except per share data) |
Earnings (loss) from continuing operations attributable to Celanese
Corporation |
|
|
902 |
|
|
6.19 |
|
160 |
|
|
1.12 |
|
265 |
|
|
1.83 |
|
221 |
|
|
1.50 |
|
256 |
|
|
1.73 |
|
306 |
|
|
2.01 |
|
(298 |
) |
|
(2.03 |
) |
|
161 |
|
|
1.07 |
|
207 |
|
|
1.34 |
|
236 |
|
|
1.53 |
Income tax provision (benefit) |
|
|
122 |
|
|
|
|
(5 |
) |
|
|
|
15 |
|
|
|
|
52 |
|
|
|
|
60 |
|
|
|
|
201 |
|
|
|
|
31 |
|
|
|
|
74 |
|
|
|
|
24 |
|
|
|
|
72 |
|
|
|
Earnings (loss) from continuing operations before tax |
|
|
1,024 |
|
|
|
|
155 |
|
|
|
|
280 |
|
|
|
|
273 |
|
|
|
|
316 |
|
|
|
|
507 |
|
|
|
|
(267 |
) |
|
|
|
235 |
|
|
|
|
231 |
|
|
|
|
308 |
|
|
|
Certain Items attributable to Celanese Corporation (Table 8)
|
|
|
130 |
|
|
|
|
106 |
|
|
|
|
7 |
|
|
|
|
9 |
|
|
|
|
8 |
|
|
|
|
611 |
|
|
|
|
490 |
|
|
|
|
41 |
|
|
|
|
65 |
|
|
|
|
15 |
|
|
|
Refinancing and related expenses |
|
|
6 |
|
|
|
|
— |
|
|
|
|
4 |
|
|
|
|
— |
|
|
|
|
2 |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
|
— |
|
|
|
Adjusted earnings (loss) from continuing operations before tax |
|
|
1,160 |
|
|
|
|
261 |
|
|
|
|
291 |
|
|
|
|
282 |
|
|
|
|
326 |
|
|
|
|
1,118 |
|
|
|
|
223 |
|
|
|
|
276 |
|
|
|
|
296 |
|
|
|
|
323 |
|
|
|
Income tax (provision) benefit on adjusted
earnings(1) |
|
|
(197 |
) |
|
|
|
(44 |
) |
|
|
|
(49 |
) |
|
|
|
(48 |
) |
|
|
|
(55 |
) |
|
|
|
(201 |
) |
|
|
|
(40 |
) |
|
|
|
(50 |
) |
|
|
|
(53 |
) |
|
|
|
(58 |
) |
|
|
Adjusted earnings (loss) from continuing
operations(2) |
|
|
963 |
|
|
6.61 |
|
217 |
|
|
1.52 |
|
242 |
|
|
1.67 |
|
234 |
|
|
1.59 |
|
271 |
|
|
1.83 |
|
917 |
|
|
6.02 |
|
183 |
|
|
1.25 |
|
|
226 |
|
|
1.50 |
|
243 |
|
|
1.58 |
|
265 |
|
|
1.72 |
|
|
|
|
|
|
|
|
|
Diluted shares (in millions)(3) |
Weighted average shares outstanding |
|
|
144.9 |
|
|
|
|
141.9 |
|
|
|
|
144.0 |
|
|
|
|
146.5 |
|
|
|
|
147.4 |
|
|
|
|
150.8 |
|
|
|
|
146.9 |
|
|
|
|
149.8 |
|
|
|
|
153.5 |
|
|
|
|
153.2 |
|
|
|
Incremental shares attributable to equity awards |
|
|
0.8 |
|
|
|
|
0.7 |
|
|
|
|
0.6 |
|
|
|
|
0.6 |
|
|
|
|
0.7 |
|
|
|
|
1.5 |
|
|
|
|
— |
|
|
|
|
1.2 |
|
|
|
|
0.5 |
|
|
|
|
0.7 |
|
|
|
Total diluted shares |
|
|
145.7 |
|
|
|
|
142.6 |
|
|
|
|
144.6 |
|
|
|
|
147.1 |
|
|
|
|
148.1 |
|
|
|
|
152.3 |
|
|
|
|
146.9 |
|
|
|
|
151.0 |
|
|
|
|
154.0 |
|
|
|
|
153.9 |
|
|
|
______________________________
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Calculated using adjusted effective tax rates (Table 3a) as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
Q4 '16 |
|
Q3 '16 |
|
Q2 '16 |
|
Q1 '16 |
|
2015 |
|
Q4 '15 |
|
Q3 '15 |
|
Q2 '15 |
|
Q1 '15 |
|
|
|
|
|
|
|
|
|
(In percentages) |
Adjusted effective tax rate |
|
|
17 |
|
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|
17 |
|
|
|
|
18 |
|
|
|
|
18 |
|
|
|
|
18 |
|
|
|
|
18 |
|
|
|
|
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) Excludes the immediate recognition of actuarial gains and losses and the impact of
actual vs. expected plan asset returns.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual Plan
Asset Returns
|
|
|
Expected
Plan Asset
Returns
|
|
|
|
|
|
|
(In percentages)
|
|
|
|
|
Q4 '16 & 2016
|
|
|
6.9
|
|
|
|
7.3
|
|
|
|
|
|
|
|
|
Q4 '15 & 2015
|
|
|
(2.5
|
)
|
|
|
7.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) Potentially dilutive shares are included in the adjusted earnings per share
calculation when adjusted earnings are positive.
|
|
|
|
|
|
|
|
|
Table 3a |
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure -
Unaudited |
|
|
|
|
|
|
|
Actual |
|
|
|
2016 |
|
|
2015 |
|
|
|
(In percentages) |
US GAAP effective tax rate |
|
|
12 |
|
|
|
41 |
|
Discrete quarterly recognition of GAAP items(1) |
|
|
1 |
|
|
|
2 |
|
Tax impact of other charges and adjustments(2) |
|
|
3 |
|
|
|
(15 |
) |
Utilization of foreign tax credits(3) |
|
|
— |
|
|
|
(2 |
) |
Changes in valuation allowances, excluding impact of other charges and
adjustments(4) |
|
|
2 |
|
|
|
(5 |
) |
Other(5) |
|
|
(1 |
) |
|
|
(3 |
) |
Adjusted tax rate |
|
|
17 |
|
|
|
18 |
|
______________________________ |
Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP
effective tax rate for actual results.
|
(1)
|
|
Such as changes in uncertain tax positions, prior year audit adjustments, changes in
tax laws and deferred taxes on outside basis differences. |
(2)
|
|
Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8),
which are excluded from pre-tax income for adjusted earnings per share purposes. During 2015, the Company recorded a $123
million long-lived impairment to fully write-off certain ethanol related assets at our facility in Nanjing, China and $174
million charge related to the termination of an existing agreement with a raw materials supplier in Singapore. For US GAAP
purposes, these charges were incurred in jurisdictions for which valuation allowances are being recorded. These combined
charges make up the majority of the 15% impact for 2015. |
(3)
|
|
During 2012, the Company amended its tax returns and recognized $142 million in
foreign tax credits for U.S. GAAP purposes. The Company reflects the benefits of these tax credits for adjusted tax rate
purposes as they are utilized. |
(4)
|
|
Reflects changes in valuation allowances related to changes in judgment regarding the
realizability of deferred tax assets or current year operations, excluding other charges and adjustments. |
(5)
|
|
Tax impacts related to full-year forecasted tax opportunities and related costs. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4 |
|
|
|
Net Sales by Segment - Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Advanced Engineered Materials |
|
|
1,444 |
|
|
|
364 |
|
|
|
365 |
|
|
|
365 |
|
|
|
350 |
|
|
|
1,326 |
|
|
|
311 |
|
|
|
326 |
|
|
|
346 |
|
|
|
343 |
|
Consumer Specialties |
|
|
929 |
|
|
|
225 |
|
|
|
225 |
|
|
|
235 |
|
|
|
244 |
|
|
|
969 |
|
|
|
246 |
|
|
|
247 |
|
|
|
249 |
|
|
|
227 |
|
Total Materials Solutions |
|
|
2,373 |
|
|
|
589 |
|
|
|
590 |
|
|
|
600 |
|
|
|
594 |
|
|
|
2,295 |
|
|
|
557 |
|
|
|
573 |
|
|
|
595 |
|
|
|
570 |
|
Industrial Specialties |
|
|
979 |
|
|
|
219 |
|
|
|
245 |
|
|
|
262 |
|
|
|
253 |
|
|
|
1,082 |
|
|
|
239 |
|
|
|
274 |
|
|
|
287 |
|
|
|
282 |
|
Acetyl Intermediates |
|
|
2,441 |
|
|
|
597 |
|
|
|
589 |
|
|
|
592 |
|
|
|
663 |
|
|
|
2,744 |
|
|
|
644 |
|
|
|
680 |
|
|
|
707 |
|
|
|
713 |
|
Eliminations(1) |
|
|
(288 |
) |
|
|
(67 |
) |
|
|
(71 |
) |
|
|
(74 |
) |
|
|
(76 |
) |
|
|
(323 |
) |
|
|
(71 |
) |
|
|
(82 |
) |
|
|
(83 |
) |
|
|
(87 |
) |
Total Acetyl Chain |
|
|
3,132 |
|
|
|
749 |
|
|
|
763 |
|
|
|
780 |
|
|
|
840 |
|
|
|
3,503 |
|
|
|
812 |
|
|
|
872 |
|
|
|
911 |
|
|
|
908 |
|
Other Activities(2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Intersegment eliminations(1) |
|
|
(116 |
) |
|
|
(27 |
) |
|
|
(30 |
) |
|
|
(29 |
) |
|
|
(30 |
) |
|
|
(124 |
) |
|
|
(35 |
) |
|
|
(32 |
) |
|
|
(29 |
) |
|
|
(28 |
) |
Net sales |
|
|
5,389 |
|
|
|
1,311 |
|
|
|
1,323 |
|
|
|
1,351 |
|
|
|
1,404 |
|
|
|
5,674 |
|
|
|
1,334 |
|
|
|
1,413 |
|
|
|
1,477 |
|
|
|
1,450 |
|
______________________________
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Includes intersegment sales as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Industrial Specialties |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Acetyl Intermediates |
|
|
(401 |
) |
|
|
(93 |
) |
|
|
(100 |
) |
|
|
(102 |
) |
|
|
(106 |
) |
|
|
(447 |
) |
|
|
(106 |
) |
|
|
(114 |
) |
|
|
(112 |
) |
|
|
(115 |
) |
Intersegment eliminations |
|
|
(404 |
) |
|
|
(94 |
) |
|
|
(101 |
) |
|
|
(103 |
) |
|
|
(106 |
) |
|
|
(447 |
) |
|
|
(106 |
) |
|
|
(114 |
) |
|
|
(112 |
) |
|
|
(115 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) Other Activities includes corporate SG&A expenses, the results of captive
insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and
net actuarial gains and losses).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4a |
Factors Affecting Segment Net Sales Sequentially - Unaudited |
|
Three Months Ended December 31, 2016 Compared to Three Months Ended
September 30, 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
1 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
— |
|
Consumer Specialties |
|
|
2 |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
— |
|
Total Materials Solutions |
|
|
2 |
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(7 |
) |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
(11 |
) |
Acetyl Intermediates |
|
|
— |
|
|
|
2 |
|
|
|
(1 |
) |
|
|
— |
|
|
1 |
|
Total Acetyl Chain |
|
|
(2 |
) |
|
|
1 |
|
|
|
(2 |
) |
|
|
1 |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(1 |
) |
|
|
1 |
|
|
|
(1 |
) |
|
|
— |
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2016 Compared to Three Months Ended June 30,
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(1 |
) |
|
|
1 |
|
|
— |
|
|
|
— |
|
|
— |
|
Consumer Specialties |
|
|
(4 |
) |
|
|
— |
|
|
— |
|
|
|
— |
|
|
(4 |
) |
Total Materials Solutions |
|
|
(2 |
) |
|
|
— |
|
|
— |
|
|
|
— |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(6 |
) |
|
|
— |
|
|
(1 |
) |
|
|
— |
|
|
(7 |
) |
Acetyl Intermediates |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
Total Acetyl Chain |
|
|
(2 |
) |
|
|
— |
|
|
(1 |
) |
|
|
1 |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(2 |
) |
|
|
— |
|
|
— |
|
|
|
— |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2016 Compared to Three Months Ended March 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
6 |
|
|
|
(2 |
) |
|
|
1 |
|
|
— |
|
|
5 |
|
Consumer Specialties |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
— |
|
|
— |
|
|
(4 |
) |
Total Materials Solutions |
|
|
2 |
|
|
|
(2 |
) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
4 |
|
|
|
(1 |
) |
|
|
1 |
|
|
— |
|
|
4 |
|
Acetyl Intermediates |
|
|
(11 |
) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
(11 |
) |
Total Acetyl Chain |
|
|
(7 |
) |
|
|
(1 |
) |
|
|
1 |
|
|
— |
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(4 |
) |
|
|
(1 |
) |
|
|
1 |
|
|
— |
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2016 Compared to Three Months Ended December 31,
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
12 |
|
|
— |
|
|
|
— |
|
|
— |
|
|
|
12 |
|
Consumer Specialties |
|
|
6 |
|
|
(7 |
) |
|
|
— |
|
|
— |
|
|
|
(1 |
) |
Total Materials Solutions |
|
|
10 |
|
|
(3 |
) |
|
|
— |
|
|
— |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
9 |
|
|
(3 |
) |
|
|
— |
|
|
— |
|
|
|
6 |
|
Acetyl Intermediates |
|
|
7 |
|
|
(4 |
) |
|
|
— |
|
|
— |
|
|
|
3 |
|
Total Acetyl Chain |
|
|
8 |
|
|
(4 |
) |
|
|
— |
|
|
(1 |
) |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
9 |
|
|
(4 |
) |
|
|
— |
|
|
— |
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2015 Compared to Three Months Ended September 30,
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(3 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
(4 |
) |
Consumer Specialties |
|
|
(1 |
) |
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
— |
|
Total Materials Solutions |
|
|
(3 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(7 |
) |
|
|
(5 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(13 |
) |
Acetyl Intermediates |
|
|
1 |
|
|
|
(7 |
) |
|
|
(1 |
) |
|
|
2 |
|
|
(5 |
) |
Total Acetyl Chain |
|
|
(2 |
) |
|
|
(7 |
) |
|
|
(1 |
) |
|
|
3 |
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(1 |
) |
|
|
(4 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2015 Compared to Three Months Ended June 30,
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
Price |
|
Currency |
|
Other |
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(5 |
) |
|
(1 |
) |
|
— |
|
— |
|
(6 |
) |
Consumer Specialties |
|
|
— |
|
|
— |
|
|
— |
|
— |
|
— |
|
Total Materials Solutions |
|
|
(3 |
) |
|
(1 |
) |
|
— |
|
— |
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(5 |
) |
|
1 |
|
|
— |
|
— |
|
(4 |
) |
Acetyl Intermediates |
|
|
(1 |
) |
|
(3 |
) |
|
— |
|
— |
|
(4 |
) |
Total Acetyl Chain |
|
|
(2 |
) |
|
(2 |
) |
|
— |
|
— |
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(3 |
) |
|
(1 |
) |
|
— |
|
— |
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4a |
Factors Affecting Segment Net Sales Sequentially - Unaudited
(Cont.) |
|
Three Months Ended June 30, 2015 Compared to Three Months Ended March
31, 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
2 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
1 |
|
Consumer Specialties |
|
|
11 |
|
|
|
(1 |
) |
|
|
— |
|
|
|
— |
|
|
10 |
|
Total Materials Solutions |
|
|
6 |
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
— |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
6 |
|
|
|
(4 |
) |
|
|
(1 |
) |
|
|
— |
|
|
1 |
|
Acetyl Intermediates |
|
|
(1 |
) |
|
|
1 |
|
|
|
(1 |
) |
|
|
— |
|
|
(1 |
) |
Total Acetyl Chain |
|
|
2 |
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
3 |
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
1 |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2015 Compared to Three Months Ended December 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
6 |
|
|
|
2 |
|
|
|
(4 |
) |
|
|
— |
|
|
4 |
|
Consumer Specialties |
|
|
(16 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
(18 |
) |
Total Materials Solutions |
|
|
(4 |
) |
|
|
— |
|
|
|
(3 |
) |
|
|
— |
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
16 |
|
|
|
(4 |
) |
|
|
(5 |
) |
|
|
— |
|
|
7 |
|
Acetyl Intermediates |
|
|
1 |
|
|
|
(11 |
) |
|
|
(3 |
) |
|
|
— |
|
|
(13 |
) |
Total Acetyl Chain |
|
|
5 |
|
|
|
(10 |
) |
|
|
(4 |
) |
|
|
1 |
|
|
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
2 |
|
|
|
(6 |
) |
|
|
(4 |
) |
|
|
1 |
|
|
(7 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4b |
Factors Affecting Segment Net Sales Year Over Year - Unaudited |
|
Three Months Ended December 31, 2016 Compared to Three Months Ended
December 31, 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
20 |
|
|
|
(2 |
) |
|
|
(1 |
) |
|
|
— |
|
|
17 |
|
Consumer Specialties |
|
|
2 |
|
|
|
(11 |
) |
|
|
— |
|
|
|
— |
|
|
(9 |
) |
Total Materials Solutions |
|
|
12 |
|
|
|
(6 |
) |
|
|
— |
|
|
|
— |
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(1 |
) |
|
|
(6 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(8 |
) |
Acetyl Intermediates |
|
|
(4 |
) |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
(7 |
) |
Total Acetyl Chain |
|
|
(4 |
) |
|
|
(3 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
2 |
|
|
|
(4 |
) |
|
|
(1 |
) |
|
|
1 |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2016 Compared to Three Months Ended September 30,
2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
16 |
|
|
|
(4 |
) |
|
|
— |
|
|
|
— |
|
|
12 |
|
Consumer Specialties |
|
|
(2 |
) |
|
|
(7 |
) |
|
|
— |
|
|
|
— |
|
|
(9 |
) |
Total Materials Solutions |
|
|
8 |
|
|
|
(5 |
) |
|
|
— |
|
|
|
— |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(1 |
) |
|
|
(9 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(11 |
) |
Acetyl Intermediates |
|
|
(3 |
) |
|
|
(11 |
) |
|
|
— |
|
|
|
1 |
|
|
(13 |
) |
Total Acetyl Chain |
|
|
(3 |
) |
|
|
(12 |
) |
|
|
— |
|
|
|
2 |
|
|
(13 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
1 |
|
|
|
(9 |
) |
|
|
— |
|
|
|
2 |
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2016 Compared to Three Months Ended June 30, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
8 |
|
|
|
(4 |
) |
|
|
1 |
|
|
— |
|
|
5 |
|
Consumer Specialties |
|
|
2 |
|
|
|
(8 |
) |
|
|
— |
|
|
— |
|
|
(6 |
) |
Total Materials Solutions |
|
|
5 |
|
|
|
(5 |
) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(1 |
) |
|
|
(8 |
) |
|
|
— |
|
|
— |
|
|
(9 |
) |
Acetyl Intermediates |
|
|
(5 |
) |
|
|
(13 |
) |
|
|
— |
|
|
2 |
|
|
(16 |
) |
Total Acetyl Chain |
|
|
(4 |
) |
|
|
(12 |
) |
|
|
— |
|
|
2 |
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
— |
|
|
|
(10 |
) |
|
|
— |
|
|
1 |
|
|
(9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2016 Compared to Three Months Ended March 31, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
5 |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
— |
|
|
2 |
|
Consumer Specialties |
|
|
17 |
|
|
(9 |
) |
|
|
— |
|
|
|
— |
|
|
8 |
|
Total Materials Solutions |
|
|
9 |
|
|
(5 |
) |
|
|
— |
|
|
|
— |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
— |
|
|
(9 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(10 |
) |
Acetyl Intermediates |
|
|
6 |
|
|
(13 |
) |
|
|
(2 |
) |
|
|
2 |
|
|
(7 |
) |
Total Acetyl Chain |
|
|
5 |
|
|
(13 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
(9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
7 |
|
|
(10 |
) |
|
|
(2 |
) |
|
|
1 |
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2015 Compared to Three Months Ended December 31,
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(2 |
) |
|
|
1 |
|
|
|
(5 |
) |
|
|
— |
|
|
(6 |
) |
Consumer Specialties |
|
|
(8 |
) |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(12 |
) |
Total Materials Solutions |
|
|
(5 |
) |
|
|
(1 |
) |
|
|
(3 |
) |
|
|
— |
|
|
(9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
8 |
|
|
|
(12 |
) |
|
|
(6 |
) |
|
|
— |
|
|
(10 |
) |
Acetyl Intermediates |
|
|
— |
|
|
|
(17 |
) |
|
|
(5 |
) |
|
|
1 |
|
|
(21 |
) |
Total Acetyl Chain |
|
|
2 |
|
|
|
(17 |
) |
|
|
(5 |
) |
|
|
3 |
|
|
(17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(1 |
) |
|
|
(11 |
) |
|
|
(5 |
) |
|
|
2 |
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, 2015 Compared to Three Months Ended September 30,
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
(7 |
) |
|
|
— |
|
|
(11 |
) |
Consumer Specialties |
|
|
(10 |
) |
|
|
(4 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(15 |
) |
Total Materials Solutions |
|
|
(7 |
) |
|
|
(2 |
) |
|
|
(4 |
) |
|
|
— |
|
|
(13 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
— |
|
|
|
(5 |
) |
|
|
(8 |
) |
|
|
— |
|
|
(13 |
) |
Acetyl Intermediates |
|
|
(6 |
) |
|
|
(15 |
) |
|
|
(6 |
) |
|
|
— |
|
|
(27 |
) |
Total Acetyl Chain |
|
|
(5 |
) |
|
|
(14 |
) |
|
|
(7 |
) |
|
|
2 |
|
|
(24 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(5 |
) |
|
|
(10 |
) |
|
|
(6 |
) |
|
|
1 |
|
|
(20 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4b |
Factors Affecting Segment Net Sales Year Over Year - Unaudited
(Cont.) |
|
Three Months Ended June 30, 2015 Compared to Three Months Ended June
30, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(9 |
) |
|
|
— |
|
|
(11 |
) |
Consumer Specialties |
|
|
(10 |
) |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(14 |
) |
Total Materials Solutions |
|
|
(5 |
) |
|
|
(2 |
) |
|
|
(5 |
) |
|
|
— |
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(1 |
) |
|
|
(4 |
) |
|
|
(9 |
) |
|
|
— |
|
|
(14 |
) |
Acetyl Intermediates |
|
|
(4 |
) |
|
|
(10 |
) |
|
|
(8 |
) |
|
|
— |
|
|
(22 |
) |
Total Acetyl Chain |
|
|
(3 |
) |
|
|
(10 |
) |
|
|
(9 |
) |
|
|
3 |
|
|
(19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(4 |
) |
|
|
(7 |
) |
|
|
(8 |
) |
|
|
2 |
|
|
(17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2015 Compared to Three Months Ended March 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
— |
|
|
|
— |
|
|
|
(8 |
) |
|
|
— |
|
|
(8 |
) |
Consumer Specialties |
|
|
(21 |
) |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(25 |
) |
Total Materials Solutions |
|
|
(9 |
) |
|
|
(2 |
) |
|
|
(5 |
) |
|
|
— |
|
|
(16 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(4 |
) |
|
|
3 |
|
|
|
(9 |
) |
|
|
— |
|
|
(10 |
) |
Acetyl Intermediates |
|
|
(2 |
) |
|
|
(7 |
) |
|
|
(6 |
) |
|
|
— |
|
|
(15 |
) |
Total Acetyl Chain |
|
|
(3 |
) |
|
|
(5 |
) |
|
|
(7 |
) |
|
|
1 |
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(6 |
) |
|
|
(3 |
) |
|
|
(7 |
) |
|
|
1 |
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4c |
Factors Affecting Segment Net Sales Year Over Year - Unaudited |
|
Year Ended December 31, 2016 Compared to Year Ended December 31,
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
11 |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
9 |
|
Consumer Specialties |
|
|
4 |
|
|
|
(8 |
) |
|
|
— |
|
|
|
— |
|
|
(4 |
) |
Total Materials Solutions |
|
|
8 |
|
|
|
(5 |
) |
|
|
— |
|
|
|
— |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
(1 |
) |
|
|
(8 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(10 |
) |
Acetyl Intermediates |
|
|
(2 |
) |
|
|
(10 |
) |
|
|
(1 |
) |
|
|
2 |
|
|
(11 |
) |
Total Acetyl Chain |
|
|
(2 |
) |
|
|
(10 |
) |
|
|
(1 |
) |
|
|
2 |
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
2 |
|
|
|
(8 |
) |
|
|
(1 |
) |
|
|
2 |
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2015 Compared to Year Ended December 31, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volume |
|
|
Price |
|
|
Currency |
|
|
Other |
|
|
Total |
|
|
|
(In percentages) |
Advanced Engineered Materials |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(7 |
) |
|
|
— |
|
|
(9 |
) |
Consumer Specialties |
|
|
(13 |
) |
|
|
(3 |
) |
|
|
(1 |
) |
|
|
— |
|
|
(17 |
) |
Total Materials Solutions |
|
|
(6 |
) |
|
|
(2 |
) |
|
|
(4 |
) |
|
|
— |
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial Specialties |
|
|
— |
|
|
|
(4 |
) |
|
|
(8 |
) |
|
|
— |
|
|
(12 |
) |
Acetyl Intermediates |
|
|
(3 |
) |
|
|
(13 |
) |
|
|
(6 |
) |
|
|
— |
|
|
(22 |
) |
Total Acetyl Chain |
|
|
(3 |
) |
|
|
(11 |
) |
|
|
(7 |
) |
|
|
2 |
|
|
(19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Company |
|
|
(4 |
) |
|
|
(8 |
) |
|
|
(6 |
) |
|
|
1 |
|
|
(17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 5 |
Free Cash Flow - Reconciliation of a Non-GAAP Measure -
Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Net cash provided by (used in) investing activities |
|
|
(439 |
) |
|
|
(247 |
) |
|
|
(54 |
) |
|
|
(63 |
) |
|
|
(75 |
) |
|
|
(558 |
) |
|
|
(97 |
) |
|
|
(107 |
) |
|
|
(181 |
) |
|
|
(173 |
) |
Net cash provided by (used in) financing activities |
|
|
(759 |
) |
|
|
(292 |
) |
|
|
265 |
|
|
|
(259 |
) |
|
|
(473 |
) |
|
|
(66 |
) |
|
|
(2 |
) |
|
|
(99 |
) |
|
|
18 |
|
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) operating activities |
|
|
893 |
|
|
|
(47 |
) |
|
|
304 |
|
|
|
349 |
|
|
|
287 |
|
|
|
862 |
|
|
|
136 |
|
|
|
173 |
|
|
|
283 |
|
|
|
270 |
|
Capital expenditures on property, plant and equipment |
|
|
(246 |
) |
|
|
(60 |
) |
|
|
(58 |
) |
|
|
(58 |
) |
|
|
(70 |
) |
|
|
(520 |
) |
|
|
(89 |
) |
|
|
(104 |
) |
|
|
(165 |
) |
|
|
(162 |
) |
Capital (distributions to) contributions from NCI |
|
|
(24 |
) |
|
|
(9 |
) |
|
|
(9 |
) |
|
|
(6 |
) |
|
|
— |
|
|
|
214 |
|
|
|
27 |
|
|
|
32 |
|
|
|
75 |
|
|
|
80 |
|
Free cash flow(1)(2) |
|
|
623 |
|
|
|
(116 |
) |
|
|
237 |
|
|
|
285 |
|
|
|
217 |
|
|
|
556 |
|
|
|
74 |
|
|
|
101 |
|
|
|
193 |
|
|
|
188 |
|
______________________________ |
(1)
|
|
Free cash flow is a liquidity measure used by the Company and is defined by the
Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and
adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our joint venture,
Fairway Methanol LLC ("Fairway"). |
(2)
|
|
Excludes required debt service and capital lease payments of $56 million and $25
million for the years ending December 31, 2016 and 2015, respectively. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 6 |
Cash Dividends Received - Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Dividends from equity method investments |
|
|
131 |
|
|
15 |
|
|
6 |
|
|
73 |
|
|
37 |
|
|
176 |
|
|
54 |
|
|
5 |
|
|
29 |
|
|
88 |
Dividends from cost method investments |
|
|
108 |
|
|
26 |
|
|
26 |
|
|
29 |
|
|
27 |
|
|
107 |
|
|
27 |
|
|
26 |
|
|
26 |
|
|
28 |
Total |
|
|
239 |
|
|
41 |
|
|
32 |
|
|
102 |
|
|
64 |
|
|
283 |
|
|
81 |
|
|
31 |
|
|
55 |
|
|
116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 7 |
Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
|
(In $ millions) |
Short-term borrowings and current installments of long-term debt - third party and
affiliates |
|
|
118 |
|
|
|
118 |
|
|
|
92 |
|
|
|
119 |
|
|
|
116 |
|
|
|
513 |
|
|
|
513 |
|
|
|
463 |
|
|
|
123 |
|
|
|
128 |
|
Long-term debt, net of unamortized deferred financing costs |
|
|
2,890 |
|
|
|
2,890 |
|
|
|
2,923 |
|
|
|
2,464 |
|
|
|
2,487 |
|
|
|
2,468 |
|
|
|
2,468 |
|
|
|
2,522 |
|
|
|
2,532 |
|
|
|
2,515 |
|
Total debt |
|
|
3,008 |
|
|
|
3,008 |
|
|
|
3,015 |
|
|
|
2,583 |
|
|
|
2,603 |
|
|
|
2,981 |
|
|
|
2,981 |
|
|
|
2,985 |
|
|
|
2,655 |
|
|
|
2,643 |
|
Cash and cash equivalents |
|
|
(638 |
) |
|
|
(638 |
) |
|
|
(1,252 |
) |
|
|
(735 |
) |
|
|
(716 |
) |
|
|
(967 |
) |
|
|
(967 |
) |
|
|
(952 |
) |
|
|
(988 |
) |
|
|
(851 |
) |
Net debt |
|
|
2,370 |
|
|
|
2,370 |
|
|
|
1,763 |
|
|
|
1,848 |
|
|
|
1,887 |
|
|
|
2,014 |
|
|
|
2,014 |
|
|
|
2,033 |
|
|
|
1,667 |
|
|
|
1,792 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 8 |
Certain Items - Unaudited |
|
The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss)
and are adjustments to non-GAAP measures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
Q4 '16 |
|
|
Q3 '16 |
|
|
Q2 '16 |
|
|
Q1 '16 |
|
|
2015 |
|
|
Q4 '15 |
|
|
Q3 '15 |
|
|
Q2 '15 |
|
|
Q1 '15 |
|
|
Income Statement Classification |
|
|
|
(In $ millions) |
|
|
|
Employee termination benefits(1) |
|
|
11 |
|
|
|
— |
|
|
|
3 |
|
|
|
3 |
|
|
5 |
|
|
53 |
|
|
33 |
|
|
|
6 |
|
|
10 |
|
|
4 |
|
|
Other charges (gains), net |
Plant/office closures |
|
|
4 |
|
|
|
1 |
|
|
|
2 |
|
|
|
— |
|
|
1 |
|
|
48 |
|
|
31 |
|
|
|
13 |
|
|
1 |
|
|
3 |
|
|
Other charges (gains), net / Cost of sales / SG&A |
Singapore contract termination |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
174 |
|
|
174 |
|
|
|
— |
|
|
— |
|
|
— |
|
|
Other charges (gains), net |
Business optimization |
|
|
7 |
|
|
|
3 |
|
|
|
1 |
|
|
|
1 |
|
|
2 |
|
|
20 |
|
|
4 |
|
|
|
6 |
|
|
5 |
|
|
5 |
|
|
Cost of sales / SG&A |
Asset impairments |
|
|
2 |
|
|
|
1 |
|
|
|
— |
|
|
|
1 |
|
|
— |
|
|
126 |
|
|
125 |
|
|
|
1 |
|
|
— |
|
|
— |
|
|
Other charges (gains), net |
(Gain) loss on disposition of business and assets, net |
|
|
(4 |
) |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
— |
|
|
4 |
|
|
(1 |
) |
|
|
— |
|
|
5 |
|
|
— |
|
|
(Gain) loss on disposition, net |
Commercial disputes(2) |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
— |
|
|
6 |
|
|
— |
|
|
|
5 |
|
|
— |
|
|
1 |
|
|
Cost of sales / Other charges (gains), net |
Write-off of other productive assets |
|
|
4 |
|
|
|
1 |
|
|
|
1 |
|
|
|
2 |
|
|
— |
|
|
39 |
|
|
— |
|
|
|
— |
|
|
39 |
|
|
— |
|
|
Cost of sales / R&D |
Employee benefit plan changes |
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
— |
|
|
4 |
|
|
(1 |
) |
|
|
2 |
|
|
1 |
|
|
2 |
|
|
Cost of sales / SG&A / R&D |
Actuarial (gain) loss on pension and postretirement plans |
|
|
102 |
|
|
|
102 |
|
|
|
— |
|
|
|
— |
|
|
— |
|
|
127 |
|
|
126 |
|
|
|
— |
|
|
1 |
|
|
— |
|
|
Cost of sales / SG&A / R&D |
Start-up costs(3) |
|
|
2 |
|
|
|
— |
|
|
|
1 |
|
|
|
1 |
|
|
— |
|
|
10 |
|
|
(1 |
) |
|
|
8 |
|
|
3 |
|
|
— |
|
|
Cost of sales |
Mergers and acquisitions |
|
|
3 |
|
|
|
2 |
|
|
|
1 |
|
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
|
— |
|
|
— |
|
|
— |
|
|
SG&A |
Certain Items attributable to Celanese Corporation |
|
|
130 |
|
|
|
106 |
|
|
|
7 |
|
|
|
9 |
|
|
8 |
|
|
611 |
|
|
490 |
|
|
|
41 |
|
|
65 |
|
|
15 |
|
|
|
______________________________ |
(1)
|
|
Primarily associated with site shutdown costs. |
(2)
|
|
Primarily associated with litigation settlement costs. |
(3)
|
|
Primarily associated with Fairway joint venture operational start-up costs. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 9 |
Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP
Measure - Unaudited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
(In $ millions,
except percentages)
|
|
|
|
|
|
|
|
|
(In $ millions,
except percentages)
|
Net earnings (loss) attributable to Celanese Corporation |
|
|
|
|
|
|
|
|
900 |
|
|
|
|
|
|
|
|
|
304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBIT (Table 1)
|
|
|
|
|
|
|
|
|
1,278 |
|
|
|
|
|
|
|
|
|
1,236 |
|
Adjusted effective tax rate (Table 3a)
|
|
|
|
|
|
|
|
|
17 |
% |
|
|
|
|
|
|
|
|
18 |
% |
Adjusted EBIT tax effected |
|
|
|
|
|
|
|
|
1,061 |
|
|
|
|
|
|
|
|
|
1,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
2015 |
|
|
Average |
|
|
2015 |
|
|
2014 |
|
|
Average |
|
|
|
(In $ millions, except percentages) |
Short-term borrowings and current installments of long-term debt - third parties and
affiliates |
|
|
118 |
|
|
513 |
|
|
316 |
|
|
|
513 |
|
|
137 |
|
|
325 |
|
Long-term debt, net of unamortized deferred financing costs |
|
|
2,890 |
|
|
2,468 |
|
|
2,679 |
|
|
|
2,468 |
|
|
2,586 |
|
|
2,527 |
|
Celanese Corporation stockholders' equity |
|
|
2,588 |
|
|
2,378 |
|
|
2,483 |
|
|
|
2,378 |
|
|
2,818 |
|
|
2,598 |
|
Invested capital |
|
|
|
|
|
|
|
|
5,478 |
|
|
|
|
|
|
|
|
|
5,450 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on invested capital (adjusted) |
|
|
|
|
|
|
|
|
19.4 |
% |
|
|
|
|
|
|
|
|
18.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) attributable to Celanese Corporation as a percentage
of invested capital |
|
|
|
|
|
|
|
|
16.4 |
% |
|
|
|
|
|
|
|
|
5.6 |
% |
Celanese Corporation
Investor Relations:
Surabhi Varshney, +1 972-443-3078
Surabhi.Varshney@celanese.com
or
Media - U.S.:
Travis Jacobsen, +1 972-443-3750
William.Jacobsen@celanese.com
or
Media - Europe:
Jens Kurth, +49(0)69 45009 1574
J.Kurth@celanese.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170201005494/en/